BIOMAT Database Logo BIOMAT Database Logo

Interleukin-10 promoter polymorphisms in rheumatoid arthritis and Felty's syndrome. 1998

G Coakley, and C C Mok, and A H Hajeer, and W E Ollier, and D Turner, and P J Sinnott, and I V Hutchinson, and G S Panayi, and J S Lanchbury
Department of Rheumatology, Guy's, King's and St Thomas' School of Medicine, Guy's Hospital, London.

OBJECTIVE To examine whether promoter polymorphisms associated with variation in interleukin-10 (IL-10) production are relevant to the development of rheumatoid arthritis (RA) or Felty's syndrome (FS). METHODS DNA was obtained from 44 FS patients, 117 RA patients and 295 controls. The promoter region between -533 and - 1120 was amplified by polymerase chain reaction, and polymorphisms detected by restriction enzyme digest or sequence-specific oligonucleotide probing. RESULTS We found no significant difference in allele or haplotype frequencies between the groups. CONCLUSIONS There is no association between FS or RA and these recently identified IL-10 promoter polymorphisms. Other genetic or environmental factors could explain the alterations in IL-10 levels seen in these conditions.

UI MeSH Term Description Entries
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D005258 Felty Syndrome A rare complication of rheumatoid arthritis with autoimmune NEUTROPENIA; and SPLENOMEGALY. Felty's Syndrome,Familial Felty Syndrome,Familial Felty's Syndrome,Rheumatoid Arthritis, Splenomegaly and Neutropenia,Familial Feltys Syndrome,Felty Syndrome, Familial,Felty's Syndrome, Familial,Feltys Syndrome,Syndrome, Familial Felty,Syndrome, Familial Felty's,Syndrome, Felty,Syndrome, Felty's
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D016753 Interleukin-10 A cytokine produced by a variety of cell types, including T-LYMPHOCYTES; MONOCYTES; DENDRITIC CELLS; and EPITHELIAL CELLS that exerts a variety of effects on immunoregulation and INFLAMMATION. Interleukin-10 combines with itself to form a homodimeric molecule that is the biologically active form of the protein. IL-10,CSIF-10,Cytokine Synthesis Inhibitory Factor,IL10,Interleukin 10

Related Publications

G Coakley, and C C Mok, and A H Hajeer, and W E Ollier, and D Turner, and P J Sinnott, and I V Hutchinson, and G S Panayi, and J S Lanchbury
IL-10 gene promoter polymorphisms in rheumatoid arthritis.
January 1998, Scandinavian journal of rheumatology,
G Coakley, and C C Mok, and A H Hajeer, and W E Ollier, and D Turner, and P J Sinnott, and I V Hutchinson, and G S Panayi, and J S Lanchbury
Felty's syndrome and rheumatoid arthritis.
January 1970, British medical journal,
G Coakley, and C C Mok, and A H Hajeer, and W E Ollier, and D Turner, and P J Sinnott, and I V Hutchinson, and G S Panayi, and J S Lanchbury
Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients.
October 2008, Clinical rheumatology,
G Coakley, and C C Mok, and A H Hajeer, and W E Ollier, and D Turner, and P J Sinnott, and I V Hutchinson, and G S Panayi, and J S Lanchbury
Felty's syndrome without rheumatoid arthritis?
May 2013, Clinical rheumatology,
G Coakley, and C C Mok, and A H Hajeer, and W E Ollier, and D Turner, and P J Sinnott, and I V Hutchinson, and G S Panayi, and J S Lanchbury
Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis.
September 2005, Clinical rheumatology,
G Coakley, and C C Mok, and A H Hajeer, and W E Ollier, and D Turner, and P J Sinnott, and I V Hutchinson, and G S Panayi, and J S Lanchbury
Interleukin-18-promoter polymorphisms are not relevant in rheumatoid arthritis.
June 2005, Tissue antigens,
G Coakley, and C C Mok, and A H Hajeer, and W E Ollier, and D Turner, and P J Sinnott, and I V Hutchinson, and G S Panayi, and J S Lanchbury
Interleukin-18 promoter polymorphisms in Egyptian patients with rheumatoid arthritis.
January 2012, The Egyptian journal of immunology,
G Coakley, and C C Mok, and A H Hajeer, and W E Ollier, and D Turner, and P J Sinnott, and I V Hutchinson, and G S Panayi, and J S Lanchbury
Association of polymorphisms in interleukin-10 gene promoter with autoantibody production in patients with rheumatoid arthritis.
September 2009, Annals of the New York Academy of Sciences,
G Coakley, and C C Mok, and A H Hajeer, and W E Ollier, and D Turner, and P J Sinnott, and I V Hutchinson, and G S Panayi, and J S Lanchbury
Interleukin-10 gene promoter polymorphism in Polish rheumatoid arthritis patients.
August 2010, International journal of immunogenetics,
G Coakley, and C C Mok, and A H Hajeer, and W E Ollier, and D Turner, and P J Sinnott, and I V Hutchinson, and G S Panayi, and J S Lanchbury
Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility.
October 1998, Lancet (London, England),
Copied contents to your clipboard!